Of the 21 patients with HNSCC who were anti-PD-1/PD-L1–naïve, 18 were evaluable for response, with an ORR of 33.3% (95% CI 13.3 to 59.0; n=6). Here, PDCD1 is linked to head and neck squamous cell carcinoma.